Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher after Nvidia Corp (NASDAQ:NVDA), in its 13F filing, disclosed a small stake in the company. As per the SEC filing, Nvidia’s stake in Recursion Pharmaceuticals was valued at $75.9 million, with 7.7 million shares. In July 2023, Nvidia disclosed a $50 million investment in Recursion. Founded in 2013, Recursion Pharmaceuticals combines experimental biology, bioinformatics, and a…